SC
CL icon

Solstein Capital’s Colgate-Palmolive CL Stock Holding History

Solstein Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.66K Sell
29
-224
-89% -$19.6K ﹤0.01% 384
2026
Q1 		$21.6K Buy
+253
New +$22.5K 0.01% 294
2025
Q3 		– Sell
-149
Closed -$13.5K – 461
2025
Q2 		$13.5K Buy
+149
New +$13.6K 0.01% 315
2020
Q3 		– Sell
-232
Closed -$17K – 205
2020
Q2 		$17K Hold
232
– – 0.04% 178
2020
Q1 		$15K Hold
232
– – 0.06% 167
2019
Q4 		$16K Buy
+232
New +$15.8K 0.03% 214

Other funds holding CL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Solstein Capital's CL Position: Q2 2026 in Review

Solstein Capital reduced its Colgate-Palmolive (CL) stake by 89% in Q2 2026, selling an estimated $19.6K and leaving 29 shares worth $2.66K. The position accounts for ﹤0.01% of the portfolio, ranked #384.

Solstein Capital first reported a position in CL in Q4 2019 and has held it in 6 quarters since. The position peaked at $21.6K in Q1 2026. 2,028 funds tracked by Wall St. Rank hold CL as of Q2 2026.

  • Solstein Capital held 29 shares of Colgate-Palmolive worth $2.66K as of Q2 2026.
  • Solstein Capital sold 224 Colgate-Palmolive shares in Q2 2026, an estimated $19.6K.
  • Colgate-Palmolive made up ﹤0.01% of Solstein Capital's portfolio in Q2 2026, its #384 holding.
  • Solstein Capital first reported a position in Colgate-Palmolive in Q4 2019 and has held it in 6 quarters since.
  • Solstein Capital's Colgate-Palmolive position peaked at $21.6K in Q1 2026.
  • 2,028 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q2 2026.

Based on Solstein Capital's 13F filing for Q2 2026, filed 13 Aug 2026.